在最新的市场动态中，Hims & Hers Health (HIMS.US) ...

Telehealth company Hims & Hers Health (NYSE:HIMS) will be reporting results this Monday after market hours. Here’s what to ...

美东时间周三，美股三大指数集体收涨，标普500指数再创历史新高，纳指收盘首次站上21000点关口。截至收盘，道指涨507.85点，涨幅为1.14%，报45010.29点；纳指涨127.33点，涨幅为0.61%，报21020.02点；标普500指数涨4 ...

智通财经APP获悉，专注于通过线上平台提供远程医疗服务和个性化健康产品的Hims & Hers Health (HIMS.US)与全球减肥药领军者诺和诺德(NVO.US)之间短暂合作关系的突然终止，导致针对这家远程医疗公司的投资者诉讼麻烦不断增加。在本周，一群股东在旧金山联邦法院对 Hims & ...

Investing.com - Hims Hers Health Inc ...

周三，Hims & Hers Health (HIMS.US)涨超7%，月内累涨30%，报64.51美元。消息面上，该公司将于美东时间08月04日盘后发布财报，机构预期2025Q2实现营收5.52亿美元，同比增加74.89%;预期每股收益0.165美元，同比增加174.5%。

Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Hims & Hers Health, Inc. (NYSE: HIMS) and certain of the Company's senior executives for ...

Hims & Hers Health ranks highest in Revenue Growth among its peers. It also leads in Gross Profit margin. However, it has the ...

Hims & Hers Health, Inc.（纳斯达克股票代码：HIMS）首席法务官Soleil Boughton于2025年7月28日以每股58.70美元的价格出售了2,572股A类普通股，总价值为150,976美元。

Hims & Hers Health ($HIMS) is scheduled to announce its results for the second quarter of 2025 after the market closes on Monday, August 4. HIMS ...

美国远程医疗平台Hims & Hers Health近日宣布，计划在加拿大推出司美格鲁肽仿制药，此举紧随该药物在加拿大的专利将于明年1月到期的消息。此举标志着Hims & Hers Health首次进军加拿大市场。 据悉，加拿大成人中超重或肥胖的比例接近三分之二，但受限于高昂的治疗费用和药品供应不足，许多患者难以获得有效的治疗方案。Hims & Hers ...

Hims & Hers Health partnered with Novo Nordisk earlier this year, only for that to unravel shortly afterward due to controversial practices around the sale of compounded drugs. These drugs are ...